Novel approach: intranasal vaccination strategy targets Omicron COVID-19 variants

FHS
July 14, 2023
9:36 am

Researchers tested the efficacy of a two to three-dose intranasal (IN) regimen of the NDV-HXP-S vaccine.

UC Davis Health experts urge wildfire preparedness action plans to support patients with respiratory diseases

A multidisciplinary team of UC Davis Health experts are calling on health systems to create wildfire preparedness action plans to support patients with preexisting respiratory

August 20, 2024

Small-molecule A485 mobilizes white blood cells on demand

New study reveals a small molecule that can selectively mobilize white blood cells, offering potential treatments for diseases with abnormal leukocyte counts.

February 4, 2024

Health Canada approves Arcutis’ ZORYVE for seborrheic dermatitis

In the Phase III STRATUM trial, 80% of patients succeeded in the treatment by week eight using ZORYVE foam. Credit: Arcutis Biotherapeutics, Inc./GlobeNewswire. Arcutis Biotherapeutics‘

October 21, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.